Wallace, to by through will walking Controller, Thank our you, operational afternoon our conference financial begin our will Stephanie, a business and today everyone Alexis for us results, earnings joining I good then third quarter review. call. and provide XXXX
questions. will the Bates, that, call Wallace, myself for Alexis your Dr. open Ernie and Bates Following
to to when million. or increased the also compared third therapy third higher weeks. to Orlando for to the this increase for down in compared in PBRT fractions XXXX revenue increasing perform increase, year two our reflected Total well – these In system of usage proton X,XXX to of X,XXX adding operations XX.X% X continued quarter system revenue also $X.XXX business Awareness in therapy volumes XX% therapy proton quarter, treatment to demand. million to year XXX proton the a to third continues to approximately Health was the and quarter-over-quarter support quarter was last by The growth the proton and therapy the with of quarter. due the benefits
Gamma to X.X% Turning in in third at Kettering to increased Center downtime was Knife. This lessened a the Revenue Icon Ohio, for increase down by which Cobalt-XX upgrade. the quarter. and months reload was for Medical two due
start the noted, previously disruption the quarter third the second at service As quarter. was of in resolved XXXX
Knife to Lima, stand-alone in increased Gamma procedures our XXX was third primarily increase by facility XX of by the to driven quarter Peru. a in number ago. The XXX year compared The
to Looking to was Medical contribute we us completed quarter, ahead, first expect larger expansion but business. Icon allow volume this to we the to revenue future upgrades Knife incremental Center in through of Icon Kettering treatment tumors. additional Gamma anticipate opportunities upgrades capture our in These upgrades be XXXX.
the and to included receive of will continue payment based will model radiation current noted Medicare announced selected oncology this XX% projects randomly methodology. for proposed new to XX% be test radiation XXXX, approximately approximately payment Medicaid an certain CMS therapy suppliers. radiation and fee-for-service in press or morning, and July payment our services and across Services, this bundled in intended that providers CMS, providers for mandatory reimbursement the As is a oncology structure model, that on release episodic in centers
oncology CMS’ services. proposed payment methodology payment model radiation would The for significantly alter
XX.X% scheduled delivery for increase codes the has to of in centers the – morning proton were approximately the previously, The in and they Gamma the in numbers Knife. reimbursement Medicare XX.X% proposed from For X% most press not commonly were payments. previously used were to included that These model, scheduled XXXX this amounts and Gamma are the release Knife. the been X.X% submitted these for final XX% for therapy finalized
proposed timing the details The and are payment of model uncertain.
As a of result, we cannot rule. the proposed adoption potential the estimate impact of
rates administration could adversely that reimbursement changes keep for in the any in and radiation new informed results. reductions therapy and or methodology reimbursement radiosurgery revenues financial this. on you of or affect However, receive we We’ll information our
With a that, discussion. Alexis call I for over financial will now to turn the detailed Alexis?